Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III study of Inpegsomatropin Injection once weekly versus daily recombinant human growth hormone in children with idiopathic short stature
CTR20251073Phase 3Active
- Sponsor
- Xiamen Tebao Biological Engineering Co., Ltd.
- Start
- Jun 2025
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of genotropin miniquick in Idiopathic Short Stature (ISS), sponsored by Xiamen Tebao Biological Engineering Co., Ltd.. Started Jun 2025; status: active.
02
Drugs
genotropin miniquick
03
Conditions
Idiopathic Short Stature (ISS)
Beyond the preview
Go deeper on CTR20251073.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20251073.